Skip to main
TDOC

Teladoc (TDOC) Stock Forecast & Price Target

Teladoc (TDOC) Analyst Ratings

Based on 16 analyst ratings
Hold
Strong Buy 13%
Buy 13%
Hold 75%
Sell 0%
Strong Sell 0%

Bulls say

Teladoc Health is well-positioned to continue its growth trajectory in the telehealth market, driven by its successful Integrated Care segment and expansion into international markets. The company's insurance offering and focus on virtual care for a variety of conditions give it a strong competitive advantage in the growing virtual healthcare space. While there are some concerns about pricing power and gross margin pressures, the company's strong leadership and ability to adapt make it a promising investment opportunity.

Bears say

Teladoc Health is facing headwinds in its BetterHelp segment, which offers direct-to-consumer mental health services. The company's new three-year targets call for low-single-digit growth in this segment, a significant drop from previous trends. This slower growth could hamper the company's overall enterprise and create uncertainty about the path forward. Additionally, increased advertising and marketing spend may not have a significant correlation with revenue growth, potentially impacting the company's profitability.

Teladoc (TDOC) has been analyzed by 16 analysts, with a consensus rating of Hold. 13% of analysts recommend a Strong Buy, 13% recommend Buy, 75% suggest Holding, 0% advise Selling, and 0% predict a Strong Sell.

This aggregate rating is based on analysts' research of Teladoc and is not a guaranteed prediction by Public.com or investment advice.

Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy

FAQs About Teladoc (TDOC) Forecast

Analysts have given Teladoc (TDOC) a Hold based on their latest research and market trends.

According to 16 analysts, Teladoc (TDOC) has a Hold consensus rating as of May 20, 2026. This rating is provided by third-party analysts and is not investment advice from Public.com.

Wall Street analysts have set a price target of $7.47, reflecting a 0.00% increase from the current stock price.

Financial analysts have set a price target of $7.47, indicating a 0.00% increase from the current stock price, but ratings and forecasts are frequently updated based on market conditions, earnings reports, and industry trends. This prediction is provided by third-party analysts and is not investment advice from Public.com.

Teladoc (TDOC)


Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy
Disclaimer: Any investment listed here, which may be available on the Public platform, is intended to be used for informational purposes only, should not be the sole basis for making an investment decision, and is not a recommendation or advice.